转换为勒沃甲改善了甲诱导的过症:一个病例报告
Tiziano Serfilippi1, Silvia Piccirillo1, Francesca Romagnoli2
1Department of Biomedical Sciences and Public Health, School of Medicine, University "Politecnica delle Marche", Ancona, Italy.
Journal of addictive diseases
|February 6, 2025
概括
利沃甲可以有效地治疗超 (过度出汗) 在接受甲维护治疗海洛因成的患者. 在一个案例研究中,从甲转换为levomethadone显著减少了出汗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
- 皮肤病学 皮肤病学
背景情况:
- 甲维持疗法是海洛因成的主要治疗方法.
- 过是经常发生的,但往往没有解决的,甲治疗的副作用.
- 目前治疗阿片类药物引起的出汗缺乏标准化.
研究的目的:
- 为了研究甲作为替代甲在管理超的疗效.
- 介绍一个患有甲诱导过症的病例研究.
主要方法:
- 一名因海洛因成而接受甲维持治疗的患者报告了持续的过.
- 患者的甲被替换为相当剂量的levomethadone.
- 在切换药物之前和之后,对汗水水平进行了监测.
主要成果:
- 患者在转换为levomethadone后,出汗显著减少.
- 过的严重程度与转换前的甲剂量增加相关.
结论:
- 利沃甲在甲维持治疗期间出现过症的患者提供了潜在的替代治疗方法.
- 需要进一步的研究来证实甲在治疗阿片类药物诱导的过症中的有效性.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
142
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
142
Opioid Analgesics: Synthetic and Semisynthetic Opioids
211
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
211
Parkinson's Disease: Treatment
192
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
192
Phase II Reactions: Methylation Reactions
122
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
122
Drug Excretion: Miscellaneous Routes
34
Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific...
34
Direct-Acting Cholinergic Agonists: Therapeutic Uses
674
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
674


